Literature DB >> 28621055

Impact of diagnostic ureteroscopy on intravesical recurrence in patients undergoing radical nephroureterectomy for upper tract urothelial cancer: a systematic review and meta-analysis.

Michele Marchioni1, Giulia Primiceri1, Luca Cindolo2, Lance J Hampton3,4, Mayer B Grob3,4, Georgi Guruli3,4, Luigi Schips2, Shahrokh F Shariat5, Riccardo Autorino3,4.   

Abstract

Aim of this study was to analyse the association between the use of diagnostic ureteroscopy (URS) and the development of intravesical recurrence (IVR) in patients undergoing radical nephroureterectomy (RNU) for high-risk upper tract urothelial carcinoma. A systematic review of the published data was performed up to December 2016, using multiple search engines to identify eligible studies. A formal meta-analysis was conducted of studies comparing patients who underwent URS before RNU with those who did not. Hazard ratios (HRs), with their 95% confidence intervals (CIs), from each study were used to calculate pooled HRs. Pooled estimates were calculated using a fixed-effects or random-effects model according to heterogeneity. Statistical analyses were performed using RevMan, version 5. Seven studies were included in the systematic review, but only six of these were deemed fully eligible for meta-analysis. Among the 2 382 patients included in the meta-analysis, 765 underwent diagnostic URS prior to RNU. All examined studies were retrospective, and the majority examined Asian populations. The IVR rate ranged from 39.2% to 60.7% and from 16.7% to 46% in patients with and without prior URS, respectively. In the pooled analysis, a statistically significant association was found between performance of URS prior to RNU and IVR (HR 1.56, 95% CI 1.33-1.88; P < 0.001). There was no heterogeneity in the observed outcomes, according to the I2 statistic of 2% (P = 0.40). Within the intrinsic limitations of this type of analysis, these findings suggest a significant association between the use of diagnostic URS and higher risk of developing IVR after RNU. Further research in this area should be encouraged to further investigate the possible causality behind this association and it potential clinical implications.
© 2017 The Authors BJU International © 2017 BJU International Published by John Wiley & Sons Ltd.

Entities:  

Keywords:  #utuc; intravesical recurrence; oncological outcomes; radical nephroureterectomy; upper tract urothelial cancer; ureteroscopy

Mesh:

Year:  2017        PMID: 28621055     DOI: 10.1111/bju.13935

Source DB:  PubMed          Journal:  BJU Int        ISSN: 1464-4096            Impact factor:   5.588


  22 in total

1.  [Impact of diagnostic ureteroscopy and biopsy on radical nephroureterectomy of upper tract urothelial carcinoma].

Authors:  R Z Ma; H Z Xia; M Lu; Z Y Zhang; Q M Zhang; J Lu; G L Wang; L L Ma
Journal:  Beijing Da Xue Xue Bao Yi Xue Ban       Date:  2019-08-18

Review 2.  UTUC in 2017: Emerging evidence on treating upper tract urothelial cancer.

Authors:  Pietro Grande; Morgan Rouprêt
Journal:  Nat Rev Urol       Date:  2017-11-28       Impact factor: 14.432

3.  Diagnostic ureteroscopy prior to nephroureterectomy for urothelial carcinoma is associated with a high risk of bladder recurrence despite technical precautions to avoid tumor spillage.

Authors:  Michael Baboudjian; Khalid Al-Balushi; Floriane Michel; Francois Lannes; Akram Akiki; Sarah Gaillet; Veronique Delaporte; Evelyne Ragni; Harry Toledano; Gilles Karsenty; Dominique Rossi; Cyrille Bastide; Eric Lechevallier; Romain Boissier
Journal:  World J Urol       Date:  2019-04-16       Impact factor: 4.226

4.  Liquid Biopsy Landscape in Patients with Primary Upper Tract Urothelial Carcinoma.

Authors:  Stephanie N Shishido; Alireza Ghoreifi; Salmaan Sayeed; George Courcoubetis; Amy Huang; Brandon Ye; Sankalp Mrutyunjaya; Inderbir S Gill; Peter Kuhn; Jeremy Mason; Hooman Djaladat
Journal:  Cancers (Basel)       Date:  2022-06-18       Impact factor: 6.575

5.  The complex relationship between upper urinary tract and bladder cancer: clinical and predictive issues.

Authors:  Francesca Sanguedolce; Luigi Cormio
Journal:  Transl Androl Urol       Date:  2018-05

Review 6.  Consultation on UTUC, Stockholm 2018 aspects of risk stratification: long-term results and follow-up.

Authors:  Mudhar N Hasan; Morgan Rouprêt; Francis Keeley; Cecilia Cracco; Robert Jones; Michael Straub; Olivier Traxer; Palle Jörn Sloth Osther; Marianne Brehmer
Journal:  World J Urol       Date:  2019-04-03       Impact factor: 4.226

7.  Development and external validation of a preoperative nomogram for predicting pathological locally advanced disease of clinically localized upper urinary tract carcinoma.

Authors:  Takashi Yoshida; Takashi Kobayashi; Takayuki Kawaura; Makito Miyake; Katsuhiro Ito; Hiroshi Okuno; Takashi Murota; Noriyuki Makita; Mutsushi Kawakita; Gen Kawa; Tomoki Kitawaki; Kiyohide Fujimoto; Hideyasu Matsuyama; Hiroaki Shiina; Haruhito Azuma; Osamu Ogawa; Hidefumi Kinoshita; Tadashi Matsuda
Journal:  Cancer Med       Date:  2020-04-06       Impact factor: 4.452

8.  Diagnostic Ureteroscopy in CT Urography-Diagnosed Upper Tract Urothelial Carcinoma: Delay in Definitive Treatment and Increased Intravesical Recurrence.

Authors:  Hadi Shsm; Elizabeth Bright; Mark Mantle; Nicholas Munro; Omar Fahmy
Journal:  Cureus       Date:  2021-06-20

9.  Impact of diagnostic ureteroscopy before radical nephroureterectomy on intravesical recurrence in patients with upper tract urothelial cancer.

Authors:  Younsoo Chung; Dong Hwan Lee; Minseung Lee; Hakju Kim; Sangchul Lee; Sung Kyu Hong; Seok-Soo Byun; Sang Eun Lee; Jong Jin Oh
Journal:  Investig Clin Urol       Date:  2020-02-04

10.  Preoperative sterile pyuria as a prognostic biomarker for intravesical recurrence in upper urinary tract urothelial carcinoma.

Authors:  Byeong Jo Jeon; Bum Sik Tae; Hoon Choi; Jae Hyun Bae; Jong Wook Kim; Hong Seok Park; Jae Young Park
Journal:  Investig Clin Urol       Date:  2019-12-19
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.